Targeting HIV-1 Envelope Glycoprotein Trimers to B Cells by Using APRIL Improves Antibody Responses

An HIV-1 vaccine remains elusive, in part because various factors limit the quantity and quality of the antibodies raised against the viral envelope glycoprotein complex (Env). We hypothesized that targeting Env vaccines directly to B cells, by fusing them to molecules that bind and activate these c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Melchers, Mark, Bontjer, Ilja, Tong, Tommy, Chung, Nancy P. Y., Klasse, Per Johan, Eggink, Dirk, Montefiori, David C., Gentile, Maurizio, Cerutti, Andrea, Olson, William C., Berkhout, Ben, Binley, James M., Moore, John P., Sanders, Rogier W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3302291/
https://ncbi.nlm.nih.gov/pubmed/22205734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.06259-11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados